CMAS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.333000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.179410E-01
Normal-vs-Stage2
2.739200E-01
Normal-vs-Stage3
5.998400E-01
Normal-vs-Stage4
9.665700E-02
Stage1-vs-Stage2
7.956000E-01
Stage1-vs-Stage3
8.262600E-01
Stage1-vs-Stage4
6.438800E-01
Stage2-vs-Stage3
9.387800E-01
Stage2-vs-Stage4
5.176800E-01
Stage3-vs-Stage4
7.030000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.369600E-01
Normal-vs-AfricanAmerican
3.235800E-01
Normal-vs-Asian
2.731800E-01
Caucasian-vs-AfricanAmerican
6.588800E-01
Caucasian-vs-Asian
7.622000E-01
AfricanAmerican-vs-Asian
6.035800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.603600E-01
Normal-vs-Female
1.889950E-01
Male-vs-Female
5.679800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.064000E-01
Normal-vs-Age(41-60Yrs)
1.157010E-01
Normal-vs-Age(61-80Yrs)
3.316400E-01
Normal-vs-Age(81-100Yrs)
1.109010E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.463400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.463600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.372200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.400400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.558600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.721600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.163600E-01
Normal-vs-Daily Drinker
5.275200E-01
Normal-vs-Weekly Drinker
5.324400E-01
Normal-vs-Occasional Drinker
3.097600E-02
Normal-vs-Social Drinker
1.427800E-01
Non Drinker-vs-Daily Drinker
9.057000E-01
Non Drinker-vs-Weekly Drinker
8.251000E-01
Non Drinker-vs-Occasional Drinker
6.243700E-03
Non Drinker-vs-Social Drinker
4.609000E-01
Daily Drinker-vs-Weekly Drinker
9.349000E-01
Daily Drinker-vs-Occasional Drinker
3.210100E-02
Daily Drinker-vs-Social Drinker
5.311400E-01
Weekly Drinker-vs-Occasional Drinker
3.208200E-02
Weekly Drinker-vs-Social Drinker
4.720000E-01
Occasional Drinker-vs-Social Drinker
6.985800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.401600E-02
Normal-vs-Grade 2
1.571500E-02
Normal-vs-Grade 3
1.992160E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.031800E-01
Grade 1-vs-Grade 3
7.827000E-01
Grade 1-vs-Grade 4
4.401600E-02
Grade 2-vs-Grade 3
2.936200E-01
Grade 2-vs-Grade 4
1.571500E-02
Grade 3-vs-Grade 4
1.992160E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.613600E-01
Normal-vs-NonDiabetic
1.952990E-01
Diabetic-vs-NonDiabetic
3.036000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.855000E-01
Normal-vs-NoPancreatitis
2.555200E-01
Pancreatitis-vs-NoPancreatitis
5.024200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.335790E-01
Normal-vs-N1
3.071600E-01
N0-vs-N1
1.569980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.584000E-04
Normal-vs-TP53-NonMutant
3.643500E-03
TP53-Mutant-vs-TP53-NonMutant
2.008000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
